App-Quantinova.ai

Incidence and Outcomes of Hospitalizations Associated With Adverse Effects of Anticoagulation in Therapeutic Use

Anne Elixhauser - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Use of Factor Xa Inhibitors in Addition to Antiplatelet Therapy in Patients With a Recent Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Trials

Oscar Maitas - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Is the Arachidonic Acid Pathway Adequately Inhibited in Shunted Infants on Aspirin?

Joyce T. Johnson - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

Low Nasal Nitric Oxide as a Prognosticator of Failing Single Ventricle Physiology in Congenital Heart Disease Patients?

Maliha Zahid - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitric oxide

Oxido-Reductive Regulation of Human Vascular Remodeling by the Orphan Receptor Tyrosine Kinase Ros1

Vinicio de Jesus Perez - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

glutathione

Effects of the Novel Factor Xa Inhibitor, Apixaban, on Elevated Levels of Thrombotic Biomarkers in Genetically Obese, Diabetic Mice

Eileen Bird - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Survival and Limb Salvage Following Lower-Extremity Revascularization Using Cryopreserved Saphenous Vein Allograft

Kenneth Cherry - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Cell Selective Cardiovascular Biology of mPGES-1

Guangrui Yang - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Angiology

Venous thrombosis

N/A

Thrombosis Prone Plaques Exhibit Inflammation Prior to Rupture: Intravascular Detection via Macrophage-targeted Optical Imaging

Tetsuya Hara - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

histamine

Differential Effects of Atorvastatin and Digeranyl Bisphosphonate on Hemostasis and Thrombosis in Hypercholesterolemic Mice

Jeff W Stevens - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Atorvastatin

Acute Sagittal Sinus Thrombosis in an Elderly Patient with Chronic Idiopathic Thrombocytopenic Purpura

Robert Paulino - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Romiplostim

miR30c Regulates Plasminogen Activator Inhibitor-1 In Platelet

Qin Wan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Efficacy of Biomimetic Peptide-Fluorosurfactant Polymer Coated Expanded Poly(tetrafluoroethylene) Vascular Grafts in a Porcine Carotid Artery Interposition Model

Lynn A. Dudash - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Platelet Cd40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes

Tom Seijkens - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Matrix Metalloproteinases Regulation in Thrombus Resolution Is Independent of TGF-? in a PAI-1 Ko Mouse Model of Venous Thrombosis

Thomas W Wakefield - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Engagement of Platelet Toll-like Receptor 9 by Classical and Novel Endogenous Ligands Promotes Platelet Hyperreactivity and Thrombosis

Yi Ma - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Inflammation-Induced Thrombogenic Phenotype in the Microvasculature: The Roles of Enhanced Platelet Production and Reactivity

Alper Yildirim - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Sodium sulfate

Interleukin 17 Promotes Endothelial Activation and Neutrophil Recruitment Through Synergistic Action with Tumor Necrosis Factor ?

Gail Newton - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Interleukin

Acute Ischemic Stroke in a 23-Year-Old Patient with Verrucous Endocarditis, Prothrombin Heterozygote Mutation, and a Patent Foramen Ovale: A Case Report and Literature Review

Qi Shi - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Warfarin

Angiogenesis Requires G-Protein-Coupled Receptor Kinase 2-Interacting Protein 1 (GIT1): A Novel GIT1-ERK1/2-Cortactin Pathway Controls Endothelial Cell Directional Migration

Jinjiang Pang - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Interleukin-10

Filters

7277 Abstracts